Insider Purchase: Director at $PHAT (PHAT) Buys 12,500 Shares

Quiver QuantitativeDec 16 08:15 ET

Shareholders in Phathom Pharmaceuticals (NASDAQ:PHAT) Have Lost 66%, as Stock Drops 12% This Past Week

Simply Wall StDec 14 09:34 ET

Do You Believe in the Growth Potential of Phathom Pharmaceuticals (PHAT)?

Yahoo FinanceDec 12 09:39 ET

Phathom Pharmaceuticals Analyst Ratings

BenzingaDec 11 13:08 ET · Ratings

Needham Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsDec 11 12:32 ET · Ratings

Phathom Pharmaceuticals: Undervalued Opportunity With Strategic Moves for Extended Exclusivity

TipRanksDec 11 11:55 ET